📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis. (2020)

First Author: Furukawa TA

Attributed to: Clinical Psychopharmacology of Depression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1176/appi.focus.18204

PubMed Identifier: 33343239

Publication URI: http://europepmc.org/abstract/MED/33343239

Type: Journal Article/Review

Volume: 18

Parent Publication: Focus (American Psychiatric Publishing)

Issue: 2

ISSN: 1541-4094